Ecosystem
Beta Site
February 2022
"We are proud to announce the success of our IPO!
Thank you to our shareholders, both historical and new, for their trust.
The €25 million fundraising gives us the means to achieve our ambitions: to become a leading player in the field of brain diseases!
August 2022 Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi "San Francisco and Shanghai – August 1, 2022 – Structure Therapeutics
August 2022 "THOUSAND OAKS, Calif. and SAN CARLOS, Calif., Aug. 4, 2022 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and ChemoCentryx, Inc., (NASDAQ: CCXI), a biopharmaceutical company focused on orally admin